Gail Model for Breast Cancer Risk
Estimates risk for breast cancer based on demographic and clinical data.
100 entries · Page 2 of 4
Estimates risk for breast cancer based on demographic and clinical data.
Predicts need for VTE prophylaxis in admitted patients.
Objectifies risk of PE, like Wells' score.
Determines severity of pancreatitis based on 8 laboratory values.
Predicts risk of MI or cardiac arrest after surgery.
Predicts risk of mechanical ventilation for longer than 48 hrs postop or reintubation within 30 days.
Identifies patients who do not require intensive care for their first episode of acute pancreatitis.
Assesses lung function, particularly in intubated patients.
Classifies severity of subarachnoid hemorrhage to predict mortality.
Grades severity of colitis secondary to immune checkpoint inhibitor therapy.
Predicts mortality at 6 months in patients with infective endocarditis.
Standardizes severity of traumatic injury based on worst injury of 6 body systems.
Estimates mortality in ICH based on age and CT findings.
Recommends who should be immediately referred for liver transplant.
Predicts risk of liver decompensation after hepatectomy for hepatocellular carcinoma (HCC).
Doses local anesthetics to help avoid toxic doses.
Screens for necrotizing soft tissue infections.
Identifies patients who are malnourished or at risk of malnutrition.
Estimates viability of an extremity after trauma, to determine need for salvage vs empiric amputation.
Estimates the maximum allowable blood loss intraoperatively before transfusion should be considered.
Assesses severity of ulcerative colitis.
Quantifies end-stage liver disease for transplant planning with sodium.
Quantifies end-stage liver disease for transplant planning.
Adds sodium to the MELD model for liver cirrhosis.
Predicts survival for patients with HCC.
Assess suitability of patients for liver transplant with cirrhosis and hepatocellular carcinoma, recommended by AASLD guidelines .
Stratifies predicted difficulty of endotracheal intubation based on anatomic features.
Measures treatment response, specifically to cytotoxic drugs, based on tumor shrinkage.
No entries match your filter.